General Information of the Compound
Compound ID
CP0871009
Compound Name
(4S,7S,10S,13S,16S,19R,22S,25S,28S,31S,34S,37S,40S,43S,46S,49S,52S,55S,58S,61S,67S)-4-((2S,5R,8S,11S,17S)-21-amino-17-((S)-2-((S)-1-((S)-1-(2-((S)-1-((S)-2-((S)-2-((2S,5S,8S,11S,14S,17S,20S)-24-amino-5,8,11,14,17-pentakis(4-aminobutyl)-20-carbamoyl-1-hydroxy-3,6,9,12,15,18-hexaoxo-4,7,10,13,16,19-hexaazatetracosan-2-ylcarbamoyl)pyrrolidine-1-carbonyl)pyrrolidin-1-yl)-1-oxopropan-2-ylamino)-2-oxoethylamino)-3-hydroxy-1-oxopropan-2-ylamino)-3-hydroxy-1-oxopropan-2-ylcarbamoyl)pyrrolidine-1-carbonyl)-11-(4-aminobutyl)-8-sec-butyl-1-(1H-indol-3-yl)-5-(mercaptomethyl)-3,6,9,12,15-pentaoxo-4,7,10,13,16-pentaazahenicosan-2-ylcarbamoyl)-52-(2-amino-2-oxoethyl)-67-(2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)-2-methylpropanamido)-16-(4-aminobutyl)-10-benzyl-7-sec-butyl-13,25,28,31,40-pentakis(2-carboxyethyl)-49-(carboxymethyl)-37,58-bis(4-hydroxybenzyl)-43,55,61-tris((R)-1-hydroxyethyl)-34-isobutyl-46-isopropyl-19-(mercaptomethyl)-22-methyl-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66-henicosaoxo-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65-henicosaazaheptacontane-1,70-dioic acid
    Show/Hide
Structure
Formula
C222H350N58O69S2
Molecular Weight
4999.713
Canonical SMILES
CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
    Show/Hide
InChI
InChI=1S/C222H350N58O69S2/c1-16-115(7)176(214(342)256-145(73-80-172(303)304)198(326)261-152(98-125-102-236-131-47-22-21-46-129(125)131)201(329)269-159(111-351)209(337)274-177(116(8)17-2)213(341)255-133(49-24-33-83-224)184(312)237-105-165(291)243-147(56-31-40-90-231)219(347)278-91-41-57-160(278)210(338)267-157(109-283)207(335)265-155(107-281)186(314)239-104-164(290)241-118(10)218(346)280-93-43-59-162(280)220(348)279-92-42-58-161(279)211(339)266-156(108-282)206(334)249-138(54-29-38-88-229)192(320)248-137(53-28-37-87-228)191(319)247-136(52-27-36-86-227)190(318)246-135(51-26-35-85-226)189(317)245-134(50-25-34-84-225)188(316)244-132(181(234)309)48-23-32-82-223)273-203(331)150(95-122-44-19-18-20-45-122)260-196(324)144(72-79-171(301)302)252-193(321)139(55-30-39-89-230)250-208(336)158(110-350)268-182(310)117(9)242-187(315)141(69-76-168(295)296)251-194(322)142(70-77-169(297)298)253-195(323)143(71-78-170(299)300)254-199(327)148(94-113(3)4)258-200(328)149(96-123-60-64-127(287)65-61-123)259-197(325)146(74-81-173(305)306)257-216(344)180(121(13)286)276-212(340)175(114(5)6)272-205(333)154(101-174(307)308)262-202(330)153(100-163(233)289)264-217(345)179(120(12)285)275-204(332)151(97-124-62-66-128(288)67-63-124)263-215(343)178(119(11)284)271-166(292)106-238-185(313)140(68-75-167(293)294)270-221(349)222(14,15)277-183(311)130(232)99-126-103-235-112-240-126/h18-22,44-47,60-67,102-103,112-121,130,132-162,175-180,236,281-288,350-351H,16-17,23-43,48-59,68-101,104-111,223-232H2,1-15H3,(H2,233,289)(H2,234,309)(H,235,240)(H,237,312)(H,238,313)(H,239,314)(H,241,290)(H,242,315)(H,243,291)(H,244,316)(H,245,317)(H,246,318)(H,247,319)(H,248,320)(H,249,334)(H,250,336)(H,251,322)(H,252,321)(H,253,323)(H,254,327)(H,255,341)(H,256,342)(H,257,344)(H,258,328)(H,259,325)(H,260,324)(H,261,326)(H,262,330)(H,263,343)(H,264,345)(H,265,335)(H,266,339)(H,267,338)(H,268,310)(H,269,329)(H,270,349)(H,271,292)(H,272,333)(H,273,331)(H,274,337)(H,275,332)(H,276,340)(H,277,311)(H,293,294)(H,295,296)(H,297,298)(H,299,300)(H,301,302)(H,303,304)(H,305,306)(H,307,308)/t115-,116-,117-,118-,119+,120+,121+,130-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,175-,176-,177-,178-,179-,180-/m0/s1
    Show/Hide
InChIKey
PPAGABXQBJOTBM-DBDONQABSA-N
Physicochemical Property
logP
-20.325
Rotatable Bonds
170
Heavy Atom Count
351
Polar Areas
2076.02
Hydrogen Bond Donor Count
72
Hydrogen Bond Acceptor Count
74
Complexity
351

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 162653029
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01356, Glucagon-like peptide 1 receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 0.15 nM
   TI
   LI
   LO
   TS